Cardiome Pharma
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Cardiome Pharma Information
Cardiome Pharma was acquired by
Cipher Pharmaceuticals.
The acquisition happend on 2018-03-28.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Vancouver
State: British Columbia
Zip:
Country: Canada
Financial Info
Stage:
post ipo debt
Raised Last:
$30M
Raised Total:$57M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.
Contact Phone:
Contact Email:
Cardiome Pharma went public on 1/20/2005 on the FRA
Listed Exchange:
FRA
IPO Date:
1/20/2005
Ticker Symbol:
72R
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
